Course overview
Projects can meet scope, schedule and budget targets yet still represent poor value for money. This occurs when options are selected without credible evidence, whole-life costs are understated, benefits are vague, procurement decisions favour price over value, or delivery teams cannot show whether intended outcomes occurred. For public bodies, banks, NGOs and large corporates, these weaknesses can lead to challenged investment cases, audit findings, stranded assets, service failures and funding decisions that cannot be defended.
This course teaches participants to assess, plan and evidence value for money throughout the project life cycle. Participants apply the economy, efficiency, effectiveness and equity framework; define measurable benefits; compare options using cost-benefit analysis, cost-effectiveness analysis and multi-criteria analysis; estimate whole-life costs; establish baselines; assess affordability; and test assumptions through sensitivity and scenario analysis. The course also covers benefits realisation, procurement evaluation, earned value management, governance, assurance and reporting for investment committees, donors and senior sponsors.
Teaching combines short instructor briefings with sector-based cases, facilitated group work, appraisal simulations and structured reviews of project evidence. Participants work progressively on a value-for-money assessment for a realistic or live project, building from the problem statement and options appraisal through to benefits measures, delivery controls and an assurance plan. They leave with a practical assessment pack that can be adapted for business cases, funding proposals, project initiation documents, procurement evaluations and post-project reviews.
The course is suited to professionals who contribute to project approvals, investment cases, donor-funded programmes, capital projects, service transformation, technology delivery or operational improvement. It is particularly relevant where projects must demonstrate credible use of public funds, shareholder funds, grant funding or constrained operating budgets.



